MTHFR C677T and A1298C gene polymorphisms and their relation to homocysteine level in Egyptian children with congenital heart diseases

Gene

Volumn 529, Issue 1, 2013, Pages 119-124

  Zidan, Haidy E ^a   Rezk, Noha A ^a   Mohammed, Doaa ^a  

^a ZAGAZIG UNIVERSITY   (Egypt)

Author keywords

Congenital heart diseases; Egyptian children; Methylenetetrahydrofolate reductase (MTHFR); Polymorphism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); HOMOCYSTEINE;

ADULT; ALLELE; ARTICLE; CHILD; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME CHEMISTRY; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK;

ASD; ATRIAL SEPTAL DEFECT; CHD; CONGENITAL HEART DISEASES; DEOXYRIBONUCLEIC ACID; DNA; ECHO; ECHOCARDIOGRAPHY; EGYPTIAN CHILDREN; HCY; HOMOCYSTEINE; METHYLENE TETRAHYDROFOLATE REDUCTASE; METHYLENETETRAHYDROFOLATE REDUCTASE (MTHFR); MTHFR; PATENT DUCTUS ARTERIOSUS; PCR-RFLP; PDA; POLYMERASE CHAIN REACTION-RESTRICTION FRAGMENT LENGTH POLYMORPHISM; POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; SNP; VENTRICULAR SEPTAL DEFECT; VSD;

ALLELES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; EGYPT; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEART DEFECTS, CONGENITAL; HOMOCYSTEINE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS;

EID: 84883552682     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.07.053     Document Type: Article

References (45)

1. 1[U+2082] and total homocysteine levels in Arab adolescent subjects: reference ranges and potential determinants. Nutr. Metab. Cardiovasc. Dis. 2012, 22(10):900-906.
2. Aléssio Ana Claudia M., Annichino-Bizzacchi Joyce M., Bydlowski Sergio P., Eberlin Marcos N., Vellasco Adriana P., Höher NelciFenalti Polymorphisms in the methylenetetrahydrofolatereductase and methionine synthase reductase genes and homocysteine levels in Brazilian children. Am. J. Med. Genet. 2004, 128A:256-260.
3. Berry R.J., et al. Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N. Engl. J. Med. 1999, 341:1485-1490.
4. Botto L.D., Yang Q. 5,10-Methylenetetrahydrofolate reductase gene variants and congential anomalies. A HuGE review. Am. J. Epidemiol. 2000, 151(9):862-877.
5. Botto L.D., Khoury M.J., Mulinare J., Erickson J.D. Periconceptional multivitamin use and the occurrence of conotruncal heart defects: results from a population based case-control study. Pediatrics 1996, 98:911-917.
6. Božović I.B., Vraneković J., Cizmarević N.S., Mahulja-Stamenković V., Prpić I., Brajenović-Milić B. MTHFR C677T and A1298C polymorphisms as a risk factor for congenital heart defects in Down syndrome. Pediatr. Int. 2011, 53(4):546-550.
7. Bu R., Gutierrez M.I., Al-Rasheed M., Belgaumi A., Bhatia K. Variable drug metabolism genes in Arab population. Pharmacogenomics J. 2004, 4(4):260-266.
8. Castro R., et al. 5,10-Methylenetetrahydrofolate reductase 677C→T and 1298A→C mutations are genetic determinants of elevated homocysteine. QJM 2003, 96(4):297-303.
9. Cordain L., Hickey M.S. Ultraviolet radiation represents an evolutionary selective pressure for the south-to-north gradient of the MTHFR 677TT genotype. Am. J. Clin. Nutr. 2006, 84(1243):1244-1245.
10. de Bree A., et al. Effect of the methylenetetrahydrofolate reductase 677C→T mutation on the relations among folate intake and plasma folate and homocysteine concentrations in a general population sample. Am. J. Clin. Nutr. 2003, 77(3):687-693.
11. Deeparani T., Radhakrishna Pillai M., Elavazhagan T. Detection of MTHFR C677T and A1298C gene polymorphism in congenital heart disease. Middle-East J. Sci. Res. 2009, 4(2):127-132.
12. Diamond J. Evolutionary biology: geography and skin colour. Nature 2005, 435:283-284.
13. Domagala T.B., Adamek L., Nizankowska E., Sanak M., Szczeklik A. Mutations C677T and A1298C of the 5,10-methylenetetrahydrofolate reductase gene and fasting plasma homocysteine levels are not associated with the increased risk of venous thromboembolic disease. Blood Coagul. Fibrinolysis 2002, 13:423-431.
14. Eid S.S., Rihani G. Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations in 200 healthy Jordanians. Clin. Lab. Sci. 2004, 17(4):200-202.
15. El-Abd D.M., Said R.M., Hanna B.M., EL-Naggar N.F. Maternal and offspring methylenetetrahydrofolatereductase gene C677T polymorphism: does it influence the prevalence of congenital heart defects in Egyptian neonates?. Comp. Clin. Pathol. 2012, 1613-1614.
16. Frederiksen J., et al. Methylenetetrahydrofolate reductase polymorphism (C677T), hyperhomocysteinemia, and risk of ischemic cardiovascular disease and venous thromboembolism. Prospective and case-control studies from the Copenhagen City Heart Study. Blood 2004, 104:3046-3051.
17. Frosst P., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat. Genet. 1995, 10:111-113.
18. García-Fragoso L., García-García I., Leavitt G., Renta J., Ayala M.A., Cadilla C.L. MTHFR polymorphisms in Puerto Rican children with isolated congenital heart disease and their mothers. Int. J. Genet. Mol. Biol. 2010, 2(3):43-47. (1).
19. Goyette P., Pai A., Milos R., Frosst P., Tran P. Gene structure of human and mouse methylene-tetrahydrofolate reductase (MTHFR). Mamm. Genome 1998, 9:652-656.
20. Gueant-Rodriguez R.M., et al. Prevalence of methylenetetrahydrofolatereductase 677T and 1298C alleles and folate status: a comparative study in Mexican, West African, and European populations. Am. J. Clin. Nutr. 2006, 83:701-707.
21. Gupta S.K., Kotwal J., Kotwal A., Dhall A., Garg S. Role of homocysteine & MTHFR C677T gene polymorphism as risk factors for coronary artery disease in young Indians. Indian J. Med. Res. 2012, 135:506-512.
22. Hernandez-Diaz S., Werler M.M., Walker A.M., Mitchell A.A. Folic acid antagonists during pregnancy and the risk of birth defects. N. Engl. J. Med. 2000, 343:1608-1614.
23. Hobbs C.A., et al. Congenital heart defects and genetic variants in the methylenetetrahydrofolate reductase gene. J. Med. Genet. 2006, 43(2):162-166.
24. Jacques P.F., et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996, 93:7-9.
25. Junker R., et al. Infant methylenetetrahydrofolate reductase 667TT genotype is a risk factor for congenital heart disease. Cardiovasc. Res. 2001, 51:251-254.
26. Kandil M.E., et al. Relation between serum homocysteine and carotid intima-media thickness in obese Egyptian children. J. Clin. Basic Cardiol. 2010, 13:8. (online).
27. Kotby A., Anwar M., El-Masry O.A., Awady M., El-Nashar A., Meguid N. Genetic variants in the methylenetetrahydrofolate reductase gene in Egyptian children with conotruncal heart defects and their mothers. Maced. J. Med. Sci. 2012, 5(1):78-84.
28. Liu C.X., et al. Association of TBX5 gene polymorphism with ventricular septal defect in the Chinese Han population. Chin. Med. J. 2009, 122:30-34.
29. McBride K.L., Fernbach S., Menesses A., Molinari L., Quay E., Pignatelli R., Towbin J.A., Belmont J.W. A family-based association study of congenital left-sided heart malformations and 5,10 methylenetetrahydrofolate reductase. Birth Defects Res. A Clin. Mol. Teratol. 2004, 70:825-830.
30. Nurk E., Tell G.S., Refsum H., Ueland P.M., Vollset S.E. Associations between maternal methylenetetrahydrofolate reductase polymorphisms and adverse outcomes of pregnancy. The Hordaland Homocysteine Study. Am. J. Med. 2004, 117:26-31.
31. Ozarda Y., Sucu D.K., Hizli B., Aslan D. Rate of T alleles and TT genotype at MTHFR 677C→T locus or C alleles and CC genotype at MTHFR 1298A→C locus among healthy subjects in Turkey: impact on homocysteine and folic acid status and reference, intervals. Cell Biochem. Funct. 2009, 27(8):568-577.
32. Pishva S.R., et al. Analysis of MTHFR and MTRR gene polymorphisms in Iranian ventricular septal defect subjects. Int. J. Mol. Sci. 2013, 14:2739-2752.
33. Rady P.L., et al. Genetic polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) in ethnic populations in Texas; a report of a novel MTHFR polymorphic site, G1793A. Am. J. Med. Genet. 2000, 1079:162-168.
34. Rajeevan H., Soundararajan U., Pakstis A.J., Kidd K.K. Introducing the Forensic Research/Reference on Genetics knowledge base, FROG-kb. Investig. Genet. 2012, 3(1):18. (1).
35. Sazci A., Ergul E., Kaya G., Kara I. Genotype and allele frequencies of the polymorphic methylenetetrahydrofolatereductase gene in Turkey. Cell Biochem. Funct. 2005, 23:51-54.
36. Shaw G.M., et al. Risks of human conotruncal heart defects associated with 32 single nucleotide polymorphisms of selected cardiovascular disease-related genes. Am. J. Med. Genet. 2005, 138:21-26.
37. Storti S., et al. Association between 5,10-methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and conotruncal heart defects. Clin. Chem. Lab. Med. 2003, 41:276-280.
38. Sun F., Flanders W.D., Yang Q., Khoury M.J. Transmission disequilibrium test (TDT) when only one parent is available: the 1-TDT. Am. J. Epidemiol. 1999, 150(1):97-104.
39. Van Beynum I.M., et al. Maternal MTHFR 677CT is a risk factor for congenital heart defects: effect modification by periconceptional folate supplementation. Eur. Heart J. 2006, 27:981-987.
40. van der Put N.M., et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?. Am. J. Hum. Genet. 1998, 62:1044-1051.
41. Van Driel L.J., et al. Two MTHFR polymorphisms, maternal vitamin-B intake, and CHDs. Birth Defects Res. A Clin. Mol. Teratol. 2008, 82:474-481.
42. Vilaseca M.A., Moyano D., Ferrer I., Artuch R. Total homocysteine in pediatric patients. Clin. Chem. 1997, 43(4):690-692.
43. Wenstrom K.D., Johanning G.L., Johnston K.E., DuBard M. Association of the C677T methylenetetrahydrofolate reductase mutation and elevated homocysteine levels with congenital cardiac malformations. Am. J. Obstet. Gynecol. 2001, 184:806-812.
44. Youssef O.I., El Sayed G.M. MTHFR 677 C→T polymorphism and the risk of cardiac septal defects: a pilot study. Life Sci. J. 2012, 9(4).
45. Zhu W.L., Li Y., Yan L., Dao J., Li S. Maternal and offspring MTHFR gene C677T polymorphism as predictors of congenital atrial septal defect and patent ductus arteriosus. Mol. Hum. Reprod. 2006, 12:51-54.